Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Genomic Valley Biotech Ltd (GVBL) Share Price & Fundamentals

Company Overview

Founded Year

1994

Listed Year

-

Headquarter

Jhajjar, India

MD/CEO

-

Website

-

Company Facts

What we do

Genomic Valley Biotech Ltd specializes in biotechnology research, plant tissue culture, and advanced human genomics services including sequencing and genetic counseling.

Founded in

1,994

Market share

Emerging player in biotechnology with diverse offerings in plant cultivation and human genomics services.

Problem solved

Provides genetically improved plants and precision genomic diagnostics addressing agricultural and healthcare challenges.

Top clients or who we serve

Farmers, healthcare providers, researchers; serves B2B, B2C segments in agriculture and genomics.

Key management

-

Our journey and innovations

Started with plant biotech in 1994; expanded to human genomics in 2025 with projects in CKD and Ayurveda-focused hair growth studies.

Where we operate

India with national and international outreach in agriculture and genomics services.

Top products or what we offer

Plant tissue-cultured plants, high-tech polyhouse cultivation, Whole Genome Sequencing, Exome Sequencing, Gut Microbiome Analysis.

Top brands

-

Raw materials needed

Plant tissue culture materials, greenhouse inputs, genomic sequencing reagents.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue primarily from commercial plant cultivation and genomic services, both recurring and project-based.

Our industry position

Positioned as an innovator in plant biotech and emerging human genomic diagnostics market.

Financial highlights

Revenue Rs. 84.39 lakh and PAT Rs. 35.61 lakh for FY 2024-25 showing strong growth from prior year.

Geographical revenue split

-

Order book

-

Whats driving growth

Innovation in genomics services, expanded product portfolio, strategic healthcare collaborations, digital platform enhancements.

Our future plans

Focus on pharmaceutical genomics, biomanufacturing, oncology biomarker discovery, and radiogenomics for cancer diagnosis.

Our green promise

Committed to organic farming and sustainable biotechnology practices.

Our people and values

Employee-focused culture promoting innovation and inclusivity, training farmers and entrepreneurs.

Key challenges ahead

Scaling genomics capabilities, market competition, regulatory compliance, technological integration.

Interesting facts

Launched integrated website with AI-based tools and synergy of traditional Ayurveda with genomics research.

Risks and strategy

Mitigating market and technology risks via collaborations, compliance, and continuous R&D investments.

Market Footprint

Top Clients

Top Clients

Farmers, healthcare providers, researchers; serves B2B, B2C segments in agriculture and genomics.

Top Products

Top Products

Plant tissue-cultured plants, high-tech polyhouse cultivation, Whole Genome Sequencing, Exome Sequencing, Gut Microbiome Analysis.

Price Movement & Share Holding

Today's High/Low

45.8145.81

52 Week High/Low

20.145.81
Past Returns

1 week

27.54%

1 month

50.45%

3 month

53.09%

1 year

46.56%

3 year

91.86%

5 year

93.91%

Share Holding

Promoters

46.06%

FII

0%

DII

0%

Retail

52.87%

Others

1.07%

Company Overview

Founded Year

1994

Listed Year

-

Headquarter

Jhajjar, India

MD/CEO

-

Website

-

Price Movement & Share Holding

Today's High/Low

45.8145.81

52 Week High/Low

20.145.81

Past Returns

1 week

27.54%

1 month

50.45%

3 month

53.09%

1 year

46.56%

3 year

91.86%

5 year

93.91%

Share Holding

Promoters

46.06%

FII

0%

DII

0%

Retail

52.87%

Others

1.07%

Company Facts

What we do

Genomic Valley Biotech Ltd specializes in biotechnology research, plant tissue culture, and advanced human genomics services including sequencing and genetic counseling.

Founded in

1994

Market share

Emerging player in biotechnology with diverse offerings in plant cultivation and human genomics services.

Problem solved

Provides genetically improved plants and precision genomic diagnostics addressing agricultural and healthcare challenges.

Top clients or who we serve

Farmers, healthcare providers, researchers; serves B2B, B2C segments in agriculture and genomics.

Our journey and innovations

Started with plant biotech in 1994; expanded to human genomics in 2025 with projects in CKD and Ayurveda-focused hair growth studies.

Where we operate

India with national and international outreach in agriculture and genomics services.

Top products or what we offer

Plant tissue-cultured plants, high-tech polyhouse cultivation, Whole Genome Sequencing, Exome Sequencing, Gut Microbiome Analysis.

Raw materials needed

Plant tissue culture materials, greenhouse inputs, genomic sequencing reagents.

Recurring vs cyclical contribution

Revenue primarily from commercial plant cultivation and genomic services, both recurring and project-based.

Our industry position

Positioned as an innovator in plant biotech and emerging human genomic diagnostics market.

Financial highlights

Revenue Rs. 84.39 lakh and PAT Rs. 35.61 lakh for FY 2024-25 showing strong growth from prior year.

Whats driving growth

Innovation in genomics services, expanded product portfolio, strategic healthcare collaborations, digital platform enhancements.

Our future plans

Focus on pharmaceutical genomics, biomanufacturing, oncology biomarker discovery, and radiogenomics for cancer diagnosis.

Our green promise

Committed to organic farming and sustainable biotechnology practices.

Our people and values

Employee-focused culture promoting innovation and inclusivity, training farmers and entrepreneurs.

Key challenges ahead

Scaling genomics capabilities, market competition, regulatory compliance, technological integration.

Interesting facts

Launched integrated website with AI-based tools and synergy of traditional Ayurveda with genomics research.

Risks and strategy

Mitigating market and technology risks via collaborations, compliance, and continuous R&D investments.

Market Footprint

Top Clients

Top Clients

Farmers, healthcare providers, researchers; serves B2B, B2C segments in agriculture and genomics.

Top Products

Top Products

Plant tissue-cultured plants, high-tech polyhouse cultivation, Whole Genome Sequencing, Exome Sequencing, Gut Microbiome Analysis.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions